Michael Morozov

Michael Morozov, PhD, is a scientist with extensive experience in pharmaceutical and materials development. Current employment at Covalon Technologies Ltd. as a Scientist began in January 2022. Prior to this, Michael served as a Pharmaceutical Scientist at Covar Pharmaceuticals from September 2019 to December 2021, focusing on drug formulation and scale-up procedures. Experience also includes a Scientist role at Qvella Corporation from April 2018 to March 2019, where formulation development and optimization for blood sample testing were key responsibilities. Earlier, Michael worked as a Research Chemist at NanoAF, developing synthetic methods for antifouling applications. Academic credentials include a PhD and MSc in Organic Chemistry from the Weizmann Institute of Science and a BASc in Molecular Bio-Chemistry from the Technion - Israel Institute of Technology.